← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 28, 2021Last known activity
Jul 25, 2025
Acquired by Novartis on Dec 1, 2025
Timeline
2010s
- Jun 1, 2013
Avidity Biosciences, Inc.— Founded
2020s
- Dec 1, 2025
Novartis— Acquired By
Drugs by trial phase (3 distinct, 10 trials)
Recent trials (15)
- NCT07250737Lead sponsorN/A—
- NCT07008469Lead sponsorPhase 3Jul 25, 2025
- NCT07038200Lead sponsorPhase 3Jun 10, 2025
- NCT06547216OfficialPhase 2Jul 25, 2024
- NCT06547216Lead sponsorPhase 2Jul 25, 2024
- NCT06411288Lead sponsorPhase 3May 30, 2024
- NCT06244082OfficialPhase 2Jan 22, 2024
- NCT06244082Lead sponsorPhase 2Jan 22, 2024
- NCT05747924Lead sponsorPhase 1/Phase 2Apr 4, 2023
- NCT05670730Lead sponsorPhase 1/Phase 2Nov 9, 2022
- NCT05670730Study directorPhase 1/Phase 2Nov 9, 2022
- NCT05479981Lead sponsorPhase 2Aug 4, 2022
- NCT05479981Study directorPhase 2Aug 4, 2022
- NCT05027269Study directorPhase 1/Phase 2Oct 28, 2021
- NCT05027269Lead sponsorPhase 1/Phase 2Oct 28, 2021
Details
- Founded
- San Diego, CA, US Jun 1, 2013
- Last known activity
- Jul 25, 2025